David Moatazedi
Chief Executive Officer chez EVOLUS, INC.
Fortune : 10 M $ au 31/03/2024
Profil
David Moatazedi is currently the President, Chief Executive Officer & Director at Evolus, Inc. and an Independent Director at Biomerica, Inc. He previously served as an Independent Director at Obalon Therapeutics, Inc., Senior Vice President at Allergan, Inc., and District Manager at.
Novartis Pharmaceuticals Corp.
Moatazedi holds an undergraduate degree from The California State University and an MBA from Pepperdine University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
EVOLUS, INC.
1,12% | 27/03/2024 | 689 614 ( 1,12% ) | 10 M $ | 31/03/2024 |
Postes actifs de David Moatazedi
| Sociétés | Poste | Début |
|---|---|---|
| EVOLUS, INC. | Chief Executive Officer | 06/05/2018 |
| BIOMERICA, INC. | Director/Board Member | 07/12/2022 |
Anciens postes connus de David Moatazedi
| Sociétés | Poste | Fin |
|---|---|---|
| RESHAPE LIFESCIENCES INC. | Director/Board Member | 30/06/2020 |
| ALLERGAN, INC. | Corporate Officer/Principal | 01/05/2018 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01/03/2005 |
Formation de David Moatazedi
| The California State University | Undergraduate Degree |
| Pepperdine University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BIOMERICA, INC. | Health Technology |
| EVOLUS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Obalon Therapeutics, Inc.
 Obalon Therapeutics, Inc. Medical SpecialtiesHealth Technology Obalon Therapeutics, Inc. focuses on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. Its product includes medical balloon technology for weight loss therapy which consists of a capsule containing a balloon that is swallowed and then remotely inflated. The company was founded on January 2, 2008 and is headquartered in Carlsbad, CA. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
